Pipeline Report

Updated February 1st, 2026

BuyandBill.com Analytics Pro Features

Unlock Full Access to
BuyandBill.com Analytics

Upgrade to BuyandBill.com Pro to access this report and the complete suite of analytics tools.

You attempted to open: Drug Pipeline Report
10+ Years of Historical Pricing Data
Unlimited Access to All Drug Pages
Comparative & Historical Drug Pricing Reports
PriceDoctoRx Self-Administered Drug Pricing
Medicare & Medicaid Claims Data
Drug Pipeline Report
Check Out New Features
Comparative Pricing Reports
Go Back
View Our Subscription Options

Search

Descriptive Alt Text

Filters

Showing results 2,441–2,448 of 4,419
Manufacturer ▼ Drug Name Indication Stage Status Route of Administration Drug Class
Lantern Pharma Inc. LP-100 Hormone-refractory prostate cancer (MHRPC) Phase 2 Trial Planned Intravenous Oncology
Lantern Pharma Inc. LP-184 Atypical Teratoid Rhabdoid Tumor (ATRT) Phase 2 Trial Planned Intravenous Oncology
Lantheus Holdings Inc. Florquinitau (MK-6240) Alzheimer's disease PDUFA Ongoing Intravenous Neurology
Lantheus Holdings Inc. PYLARIFY (piflufolastat F 18) Injection Prostate Cancer PDUFA Ongoing Intravenous Oncology
Lantheus Holdings Inc. LNTH-2501 (Gallium-68 edotreotide) Neuroendocrine tumors (NETs) in adult and pediatric patients PDUFA Ongoing Intravenous Oncology
Lantheus Holdings Inc. Lutetium Lu 177 Dotatate (177Lu-PNT2003) Somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumors (GEP-NETs) ANDA Filing Intravenous Oncology
Lantheus Holdings Inc. NAV-4694 - (F18-flutafuranol) Alzheimer's disease Phase 3 Ongoing Intravenous Neurology
Lantheus Holdings Inc. 177Lu-PNT2002 - (SPLASH) Metastatic Castration-Resistant Prostate Cancer Phase 3 Data Released Intravenous Oncology
1…304305306307308…553
Your trusted source for drug reimbursement data and buy-and-bill insights.
Platform
Resources
Tools
Search Drugs
Newsletter
Reimbursement updates, drug pricing news.
© 2026 BuyandBill.com, All Rights Reserved.
HCPCS Level II codes and descriptors are approved and maintained jointly by the alpha-numeric editorial panel (consisting of CMS, America's Health Insurance Plans, and Blue Cross and Blue Shield Association). CPT® codes and descriptions are copyright American Medical Association (AMA). All rights reserved.